Skip to main content
. 2007 Feb 26;402(Pt 3):503–513. doi: 10.1042/BJ20061064

Figure 5. Inhibitory effect of the haemopexin-like domain on the proteolytic processing of fibrinogen by MMP-2.

Figure 5

SDS/PAGE electrophoresis of fibrinogen degradation by whole MMP-2 after 20 h at 37 °C in the absence (lane 2) and in the presence of 200 μM haemopexin-like domain (lane 4). Lane 3 shows the intact fibrinogen. Lane 1 shows the the low molecular mass markers and lane 5 shows the broad molecular mass markers. Chains of fibrinogen and the haemopexin-like domain are indicated by arrows. For further details, see text.